Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chk2 activates E2F-1 in response to DNA damage.

Craig Stevens1, Linda Smith, Nicholas B La Thangue

  • 1Division of Biochemistry and Molecular Biology, Davidson Building, University of Glasgow, Glasgow, G12 8QQ, UK.

Nature Cell Biology
|April 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnoses of pulmonary embolism from non-contrast 4DCT using image processing-derived quantitative perfusion scores.

npj biomedical innovations·2026
Same author

Commissioning and clinical implementation of Monaco treatment planning system on a compact pencil beam scanning proton therapy system.

Journal of applied clinical medical physics·2026
Same author

Recommendations for contouring of gross tumour volume for locally advanced lung cancer using magnetic resonance imaging.

Physics and imaging in radiation oncology·2026
Same author

Inpatient prescribing trends and differences in drug acquisition costs of long-acting injectable subcutaneous risperidone versus paliperidone palmitate: A single-center medication use evaluation.

The mental health clinician·2026
Same author

Separate transcription and splicing gene networks are linked and coordinated by the pRb-E2F pathway.

Nucleic acids research·2026
Same author

Integrated Biomimetic 2D-LC and Permeapad<sup>®</sup> Assay for Profiling the Transdermal Diffusion of Pharmaceutical Compounds.

Molecules (Basel, Switzerland)·2026

Checkpoint kinase 2 (Chk2) activates the E2F-1 transcription factor following DNA damage. This Chk2-mediated phosphorylation stabilizes E2F-1, promoting apoptosis and suggesting a role in tumor suppression.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • E2F-1 transcription factor activity is crucial for cell cycle progression.
  • Cellular stress, particularly DNA damage, induces E2F-1.
  • Checkpoint kinase 2 (Chk2) is a key regulator in DNA damage response pathways.

Purpose of the Study:

  • To investigate the regulatory role of Chk2 in E2F-1 activity upon DNA damage.
  • To elucidate the mechanism by which Chk2 influences E2F-1 function and downstream effects.

Main Methods:

  • Utilized etoposide as a DNA-damaging agent.
  • Analyzed Chk2 phosphorylation of E2F-1 using molecular biology techniques.
  • Assessed E2F-1 stabilization, transcriptional activity, and localization.

Related Experiment Videos

  • Employed dominant-negative Chk2 mutants in cellular assays.
  • Examined etoposide-induced apoptosis in tumor cells with wild-type and mutant Chk2.

    • Main Results:

    • Chk2 phosphorylates a specific site on E2F-1 in response to DNA damage.
    • Phosphorylation by Chk2 leads to E2F-1 protein stabilization and increased half-life.
    • Phosphorylated E2F-1 exhibits enhanced transcriptional activation and distinct nuclear localization.
    • Inhibition of Chk2 activity blocks E2F-1 induction and subsequent apoptosis.
    • Tumor cells with mutant Chk2 show resistance to etoposide-induced E2F-1 activation.

    Conclusions:

    • Chk2 directly phosphorylates and activates E2F-1 in response to DNA damage.
    • This Chk2-E2F-1 pathway is critical for inducing apoptosis after DNA damage.
    • E2F-1 plays a role in DNA damage checkpoint control.
    • The findings provide a mechanistic link between Chk2, E2F-1, and tumor suppression.